North America Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity

April 2023 | 178 pages | ID: NBE7C615DDD8EN
GMD Research

Abstracts

North America clinical trials market is projected to grow by 7.1% annually in the forecast period and reach $39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.

Highlighted with 89 tables and 75 figures, this 178-page report “North America Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.

Based on Product Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Trials of Drugs
• Small Molecule Drugs
• Vaccines
• Cell & Gene Therapy
• Other Drugs
• Trials of Devices
• Trials of Procedures

Based on Phase, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Phase I
• Phase II
• Phase III
• Phase IV

By Design, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Interventional Studies
• Randomized Control Trial
• Adaptive Clinical Trial
• Non-randomized Control Trial
• Observational Studies
• Cohort Study
• Case Control Study
• Cross Sectional Study
• Ecological Study
• Expanded Access Trials

By Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Clinical Trial Supply & Logistic Services
• Decentralized Clinical Trial Services
• Medical Device Testing Services
• Other Clinical Trial Services

By Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Oncology
• Infectious Diseases
• Cardiology
• Obesity
• Diabetes
• Neurology
• Immunology
• Pain Management
• Other Indications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Pharmaceutical and Biotechnological Companies
• Clinical Research Organizations
• Clinical Testing Laboratories
• Other End Users

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of each national market by Phase, Design, and Indication over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Accell Clinical Research LLC

Charles River Laboratories

ClinDatrix Inc

Clinipace

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

ICON PLC

IQVIA Holdings, Inc.

Laboratory Corporation of America (Covance Inc.)

Novo Nordisk AS

PAREXEL International Corporation

Pfizer Inc.

Pharmaceutical Product Development LLC

PhlexNorth America

PRA Health Sciences

Sanofi SA

SGS SA (SGS Life Sciences)

Syneos Health Inc.

Wuxi AppTec Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT CATEGORY

3.1 Market Overview by Product Category
3.2 Trials of Drugs
  3.2.1 Small Molecule Drugs
  3.2.2 Vaccines
  3.2.3 Cell & Gene Therapy
  3.2.4 Other Drugs
3.3 Trials of Devices
3.4 Trials of Procedures

4 SEGMENTATION OF NORTH AMERICA MARKET BY PHASE

4.1 Market Overview by Phase
4.2 Phase I
4.3 Phase II
4.4 Phase III
4.5 Phase IV

5 SEGMENTATION OF NORTH AMERICA MARKET BY DESIGN

5.1 Market Overview by Design
5.2 Interventional Studies
  5.2.1 Randomized Control Trial
  5.2.2 Adaptive Clinical Trial
  5.2.3 Non-randomized Control Trial
5.3 Observational Studies
  5.3.1 Cohort Study
  5.3.2 Case Control Study
  5.3.3 Cross Sectional Study
  5.3.4 Ecological Study
5.4 Expanded Access Trials

6 SEGMENTATION OF NORTH AMERICA MARKET BY SERVICE TYPE

6.1 Market Overview by Service Type
6.2 Protocol Designing
6.3 Site Identification
6.4 Patient Recruitment
6.5 Laboratory Services
6.6 Bioanalytical Testing Services
6.7 Clinical Trial Data Management Services
6.8 Clinical Trial Supply & Logistic Services
6.9 Decentralized Clinical Trial Services
6.10 Medical Device Testing Services
6.11 Other Clinical Trial Services

7 SEGMENTATION OF NORTH AMERICA MARKET BY INDICATION

7.1 Market Overview by Indication
7.2 Oncology
7.3 Infectious Diseases
7.4 Cardiology
7.5 Obesity
7.6 Diabetes
7.7 Neurology
7.8 Immunology
7.9 Pain Management
7.10 Other Indications

8 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

8.1 Market Overview by End User
8.2 Pharmaceutical and Biotechnological Companies
8.3 Clinical Research Organizations
8.4 Clinical Testing Laboratories
8.5 Other End Users

9 NORTH AMERICA MARKET 2021-2031 BY COUNTRY

9.1 Overview of North America Market
9.2 U.S.
9.3 Canada
9.4 Mexico

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
Phlexglobal
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of North America Clinical Trials Market in Balanced Perspective, 2022-2031
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021
Table 3. World Economic Outlook, 2021-2031
Table 4. World Economic Outlook, 2021-2023
Table 5. Scenarios for Economic Impact of Ukraine Crisis
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in North America Clinical Trials Market
Table 8. North America Clinical Trials Market by Product Category, 2021-2031, $ mn
Table 9. North America Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn
Table 10. North America Clinical Trials Market by Phase, 2021-2031, $ mn
Table 11. North America Clinical Trials Market by Design, 2021-2031, $ mn
Table 12. North America Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn
Table 13. North America Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn
Table 14. North America Clinical Trials Market by Service Type, 2021-2031, $ mn
Table 15. North America Clinical Trials Market by Indication, 2021-2031, $ mn
Table 16. North America Clinical Trials Market by End User, 2021-2031, $ mn
Table 17. North America Clinical Trials Market by Country, 2021-2031, $ mn
Table 18. U.S. Clinical Trials Market by Phase, 2021-2031, $ mn
Table 19. U.S. Clinical Trials Market by Design, 2021-2031, $ mn
Table 20. U.S. Clinical Trials Market by Indication, 2021-2031, $ mn
Table 21. Canada Clinical Trials Market by Phase, 2021-2031, $ mn
Table 22. Canada Clinical Trials Market by Design, 2021-2031, $ mn
Table 23. Canada Clinical Trials Market by Indication, 2021-2031, $ mn
Table 24. Mexico Clinical Trials Market by Phase, 2021-2031, $ mn
Table 25. Mexico Clinical Trials Market by Design, 2021-2031, $ mn
Table 26. Mexico Clinical Trials Market by Indication, 2021-2031, $ mn
Table 27. Percentage of Registered Studies by Location (as of February 24, 2022)
Table 28. Percentage of Recruiting Studies by Location (as of February 24, 2022)
Table 29. Accell Clinical Research LLC: Company Snapshot
Table 30. Accell Clinical Research LLC: Business Segmentation
Table 31. Accell Clinical Research LLC: Product Portfolio
Table 32. Charles River Laboratories: Company Snapshot
Table 33. Charles River Laboratories: Product Portfolio
Table 34. Charles River Laboratories: Breakdown of Revenue by Division
Table 35. Charles River Laboratories: Breakdown of Revenue by Region
Table 36. ClinDatrix Inc: Company Snapshot
Table 37. Clinipace: Company Snapshot
Table 38. Clinipace: Product Portfolio
Table 39. Eli Lilly and Company: Company Snapshot
Table 40. Eli Lilly and Company: Pharmaceutical Brands
Table 41. Eli Lilly and Company: Clinical Trial Service
Table 42. Eli Lilly and Company: Breakdown of Revenue by Therapeutic Area
Table 43. Eli Lilly and Company: Breakdown of Revenue by Region
Table 44. F. Hoffmann-La Roche: Company Snapshot
Table 45. F. Hoffmann-La Roche: Clinical Trial Service
Table 46. F. Hoffmann-La Roche: Business Segmentation
Table 47. F. Hoffmann-La Roche: Revenue by Region
Table 48. ICON Plc: Company Snapshot
Table 49. ICON Plc: Business Segmentation
Table 50. ICON Plc: Product Portfolio
Table 51. ICON Plc: Revenue by Region, 2020, %
Table 52. IQVIA Holdings Inc.: Company Snapshot
Table 53. IQVIA Holdings Inc.: Business Segmentation
Table 54. IQVIA Holdings Inc.: Revenue by Region, 2020, %
Table 55. IQVIA Holdings Inc.: Product Portfolio
Table 56. Covance Inc.: Company Snapshot
Table 57. Covance Inc.: Product Portfolio
Table 58. Covance Inc.: Revenue by Region, 2020, %
Table 59. Novo Nordisk: Company Snapshot
Table 60. Novo Nordisk: Product Portfolio
Table 61. Novo Nordisk: Breakdown of Revenue by Business Segment
Table 62. Novo Nordisk: Breakdown of Revenue by Region
Table 63. PAREXEL International Corporation: Company Snapshot
Table 64. PAREXEL International Corporation: Business Segmentation
Table 65. PAREXEL International Corporation: Revenue by Region, 2018, %
Table 66. PAREXEL International Corporation: Product Portfolio
Table 67. Pfizer Inc.: Company Snapshot
Table 68. Pfizer Inc.: Business Segmentation
Table 69. Pfizer Inc.: Breakdown of Revenue by Product Category
Table 70. Pfizer Inc.: Breakdown of Revenue by Region
Table 71. Pfizer Inc.: Product Portfolio
Table 72. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 73. Pharmaceutical Product Development LLC (PPD): Company Snapshot
Table 74. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Division
Table 75. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Region
Table 76. Phlexglobal: Company Snapshot
Table 77. PRA Health Sciences Inc.: Company Snapshot
Table 78. PRA Health Sciences Inc.: Business Segmentation
Table 79. PRA Health Sciences Inc.: Revenue by Region, 2018, %
Table 80. Sanofi: Company Snapshot
Table 81. Sanofi: Business Segmentation
Table 82. Sanofi: Breakdown of Revenue by Region
Table 83. SGS SA (SGS Life Sciences): Company Snapshot
Table 84. SGS SA (SGS Life Sciences): Business Segmentation
Table 85. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %
Table 86. Syneos Health Inc.: Company Snapshot
Table 87. Syneos Health Inc.: Business Segmentation
Table 88. Syneos Health Inc.: Revenue by Region, 2020, %
Table 89. WuXi AppTec Inc.: Company Snapshot

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2031
Figure 4. North America Clinical Trials Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Clinical Trials Market
Figure 7. Percentage of Trial Participants by Country, 2015-2019
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of North America Clinical Trials Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of North America Clinical Trials Market
Figure 14. Breakdown of North America Clinical Trials Market by Product Category, 2021-2031, % of Revenue
Figure 15. North America Addressable Market Cap in 2023-2031 by Product Category, Value ($ mn) and Share (%)
Figure 16. North America Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn
Figure 17. North America Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn
Figure 18. North America Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn
Figure 19. North America Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn
Figure 20. North America Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn
Figure 21. North America Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn
Figure 22. North America Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn
Figure 23. Breakdown of North America Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue
Figure 24. North America Addressable Market Cap in 2023-2031 by Phase, Value ($ mn) and Share (%)
Figure 25. North America Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn
Figure 26. North America Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn
Figure 27. North America Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn
Figure 28. North America Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn
Figure 29. Breakdown of North America Clinical Trials Market by Design, 2021-2031, % of Sales Revenue
Figure 30. North America Addressable Market Cap in 2023-2031 by Design, Value ($ mn) and Share (%)
Figure 31. North America Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn
Figure 32. North America Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn
Figure 33. North America Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn
Figure 34. North America Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn
Figure 35. North America Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn
Figure 36. North America Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn
Figure 37. North America Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn
Figure 38. North America Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn
Figure 39. North America Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn
Figure 40. North America Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn
Figure 41. Breakdown of North America Clinical Trials Market by Service Type, 2021-2031, % of Revenue
Figure 42. North America Addressable Market Cap in 2023-2031 by Service Type, Value ($ mn) and Share (%)
Figure 43. North America Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn
Figure 44. North America Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn
Figure 45. North America Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn
Figure 46. North America Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn
Figure 47. North America Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn
Figure 48. North America Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn
Figure 49. North America Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn
Figure 50. North America Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn
Figure 51. North America Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn
Figure 52. North America Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn
Figure 53. Breakdown of North America Clinical Trials Market by Indication, 2021-2031, % of Revenue
Figure 54. North America Addressable Market Cap in 2023-2031 by Indication, Value ($ mn) and Share (%)
Figure 55. North America Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn
Figure 56. North America Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn
Figure 57. North America Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn
Figure 58. North America Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn
Figure 59. North America Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn
Figure 60. North America Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn
Figure 61. North America Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn
Figure 62. North America Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn
Figure 63. North America Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn
Figure 64. Breakdown of North America Clinical Trials Market by End User, 2021-2031, % of Revenue
Figure 65. North America Addressable Market Cap in 2023-2031 by End User, Value ($ mn) and Share (%)
Figure 66. North America Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn
Figure 67. North America Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn
Figure 68. North America Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn
Figure 69. North America Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn
Figure 70. Breakdown of North America Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 71. Contribution to North America 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 72. U.S. Clinical Trials Market, 2021-2031, $ mn
Figure 73. Canada Clinical Trials Market, 2021-2031, $ mn
Figure 74. Clinical Trials Market in Mexico, 2021-2031, $ mn
Figure 75. Growth Stage of North America Clinical Trials Industry over the Forecast Period